4.7 Article

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia

Journal

NEUROBIOLOGY OF DISEASE
Volume 166, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2022.105650

Keywords

L-DOPA-induced dyskinesia; Dystonia; Synaptic dysfunction; Synaptic plasticity; Neurotransmitters; Receptors; Striatum; Basal ganglia; Parkinson's disease

Categories

Funding

  1. Dystonia Medical Research Foundation
  2. American Parkinson Disease Association
  3. United States Department of Defense [PR191874]
  4. National Institutes of Health [R56NS124764, NS108675]
  5. Parkinson's Foundation

Ask authors/readers for more resources

This review provides an overview of synaptic dysfunctions and neurochemical alterations in hyperkinetic movement disorders, including changes in synaptic plasticity and neuromodulation.
This review provides an overview of the synaptic dysfunctions of neuronal circuits and underlying neurochemical alterations observed in the hyperkinetic movement disorders, dystonia and dyskinesia. These disorders exhibit similar changes in expression of synaptic plasticity and neuromodulation. This includes alterations in physical attributes of synapses, synaptic protein expression, and neurotransmitter systems, such as glutamate and gammaaminobutyric acid (GABA), and neuromodulators, such as dopamine, acetylcholine, serotonin, adenosine, and endocannabinoids. A full understanding of the mechanisms and consequences of disruptions in synaptic function and plasticity will lend insight into the development of these disorders and new ways to combat maladaptive changes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available